Lucid Diagnostics Inc.
LUCD
$1.01
$0.021.57%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.26M | 1.50M | 1.21M | 1.16M | 828.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.26M | 1.50M | 1.21M | 1.16M | 828.00K |
| Cost of Revenue | 1.63M | 1.86M | 1.70M | 1.56M | 1.55M |
| Gross Profit | -369.00K | -356.00K | -486.00K | -400.00K | -723.00K |
| SG&A Expenses | 10.43M | 11.83M | 9.90M | 9.62M | 10.23M |
| Depreciation & Amortization | 105.00K | 105.00K | 105.00K | 105.00K | 105.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 13.37M | 15.52M | 12.97M | 12.55M | 13.32M |
| Operating Income | -12.11M | -14.01M | -11.76M | -11.38M | -12.49M |
| Income Before Tax | -13.91M | -16.27M | -10.40M | -4.44M | -26.91M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -13.91M | -16.27M | -10.40M | -4.44M | -26.91M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -13.91M | -16.27M | -10.40M | -4.44M | -26.91M |
| EBIT | -12.11M | -14.01M | -11.76M | -11.38M | -12.49M |
| EBITDA | -11.89M | -13.80M | -11.54M | -11.16M | -12.27M |
| EPS Basic | -0.17 | -0.12 | -0.10 | -0.08 | -0.52 |
| Normalized Basic EPS | -0.05 | -0.07 | -0.07 | -0.07 | -0.11 |
| EPS Diluted | -0.17 | -0.12 | -0.10 | -0.08 | -0.52 |
| Normalized Diluted EPS | -0.05 | -0.07 | -0.07 | -0.07 | -0.11 |
| Average Basic Shares Outstanding | 140.10M | 131.39M | 108.18M | 98.99M | 68.80M |
| Average Diluted Shares Outstanding | 140.10M | 131.39M | 108.18M | 98.99M | 68.80M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |